James T. Forbes

4.3k total citations
40 papers, 1.7k citations indexed

About

James T. Forbes is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, James T. Forbes has authored 40 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Immunology and 12 papers in Oncology. Recurrent topics in James T. Forbes's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Rangeland and Wildlife Management (7 papers) and Immune Cell Function and Interaction (6 papers). James T. Forbes is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Rangeland and Wildlife Management (7 papers) and Immune Cell Function and Interaction (6 papers). James T. Forbes collaborates with scholars based in United States, Canada and France. James T. Forbes's co-authors include Carlos L. Arteaga, Anne E.G. Lenferink, Jean F. Simpson, Hirokazu Kurokawa, B M Fendly, Stephen D. Hurd, Mark X. Sliwkowski, Paul I. Pisacane, Susan A. Halter and Teresa C. Dugger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

James T. Forbes

40 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James T. Forbes United States 19 856 793 286 268 176 40 1.7k
Christoph Bucher Switzerland 13 964 1.1× 882 1.1× 221 0.8× 146 0.5× 306 1.7× 21 2.3k
Arthur M. Bruskin United States 16 1.4k 1.7× 892 1.1× 285 1.0× 200 0.7× 191 1.1× 20 2.0k
Zhenlin Ju United States 35 2.3k 2.6× 1.3k 1.7× 672 2.3× 360 1.3× 599 3.4× 73 3.7k
Frank J. Calzone United States 23 1.6k 1.8× 403 0.5× 98 0.3× 567 2.1× 193 1.1× 43 2.1k
Yves Courty France 24 549 0.6× 288 0.4× 128 0.4× 85 0.3× 217 1.2× 66 1.4k
Jan Steffen Poland 19 656 0.8× 404 0.5× 198 0.7× 235 0.9× 285 1.6× 38 1.3k
R. Monier France 32 2.2k 2.6× 729 0.9× 133 0.5× 659 2.5× 163 0.9× 95 3.5k
I Sures Germany 21 1.7k 2.0× 387 0.5× 827 2.9× 215 0.8× 125 0.7× 26 2.6k
James T. Platt United States 19 882 1.0× 562 0.7× 307 1.1× 293 1.1× 272 1.5× 28 1.8k
Jill E. Larsen United States 27 1.9k 2.2× 945 1.2× 195 0.7× 258 1.0× 876 5.0× 49 2.8k

Countries citing papers authored by James T. Forbes

Since Specialization
Citations

This map shows the geographic impact of James T. Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James T. Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James T. Forbes more than expected).

Fields of papers citing papers by James T. Forbes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James T. Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James T. Forbes. The network helps show where James T. Forbes may publish in the future.

Co-authorship network of co-authors of James T. Forbes

This figure shows the co-authorship network connecting the top 25 collaborators of James T. Forbes. A scholar is included among the top collaborators of James T. Forbes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James T. Forbes. James T. Forbes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Severson, John P., Christian A. Hagen, Jason D. Tack, et al.. (2017). Better living through conifer removal: A demographic analysis of sage-grouse vital rates. PLoS ONE. 12(3). e0174347–e0174347. 31 indexed citations
2.
Severson, John P., Christian A. Hagen, Jeremy D. Maestas, et al.. (2016). Effects of conifer expansion on greater sage‐grouse nesting habitat selection. Journal of Wildlife Management. 81(1). 86–95. 31 indexed citations
3.
Miller, Todd W., James T. Forbes, Chirayu Shah, et al.. (2009). Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells. Clinical Cancer Research. 15(23). 7266–7276. 99 indexed citations
4.
Ritter, Christoph A., Teresa C. Dugger, James T. Forbes, et al.. (2004). Mechanisms of resistance development against trastuzumab (Herceptin) in an in vivo breast cancer model. International Journal of Clinical Pharmacology and Therapeutics. 42(11). 642–643. 11 indexed citations
5.
Muraoka-Cook, Rebecca S., Hirokazu Kurokawa, Yasuhiro Koh, et al.. (2004). Conditional Overexpression of Active Transforming Growth Factor β1 In vivo Accelerates Metastases of Transgenic Mammary Tumors. Cancer Research. 64(24). 9002–9011. 131 indexed citations
6.
Reyzer, Michelle L., Robert L. Caldwell, Teresa C. Dugger, et al.. (2004). Early Changes in Protein Expression Detected by Mass Spectrometry Predict Tumor Response to Molecular Therapeutics. Cancer Research. 64(24). 9093–9100. 110 indexed citations
7.
Lenferink, Anne E.G., Jean F. Simpson, Laura K. Shawver, et al.. (2000). Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-α bigenic mice. Proceedings of the National Academy of Sciences. 97(17). 9609–9614. 112 indexed citations
8.
Kurokawa, Hirokazu, Anne E.G. Lenferink, Jean F. Simpson, et al.. (2000). Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells.. PubMed. 60(20). 5887–94. 310 indexed citations
9.
Arteaga, Carlos L., et al.. (1993). Evidence for a positive role of transforming growth factor-β in human breast cancer cell tumorigenesis. Journal of Cellular Biochemistry. 53(S17G). 187–193. 22 indexed citations
10.
King, Landon S., et al.. (1989). Human recombinant interleukin 2-activated sheep lymphocytes lyse sheep pulmonary microvascular endothelial cells. Cellular Immunology. 122(1). 188–199. 10 indexed citations
11.
Stewart, Samantha, et al.. (1989). Bacterial toxins affect early events of T lymphocyte activation.. Journal of Clinical Investigation. 83(1). 234–242. 40 indexed citations
12.
Halter, Susan A., et al.. (1986). Effects of orally administered retinol on natural killer cell activity in wild type BALB/c and congenitally athymic BALB/c mice. Cancer Immunology Immunotherapy. 21(2). 114–8. 19 indexed citations
13.
Abé, Tatsuya, James T. Forbes, & Daniel G. Colley. (1983). Natural Killer Cell Activity during Murine Schistosomiasis mansoni. Journal of Parasitology. 69(6). 1001–1001. 7 indexed citations
14.
Richardson, Ronald L., Mehmet F. Fer, Kenneth R. Hande, et al.. (1982). The Unrecognized Extragonadal Germ Cell Cancer Syndrome. The Journal of Urology. 127(4). 835–835. 1 indexed citations
15.
Forbes, James T., et al.. (1981). Immune response to chemically induced tumours: correlation of responding cell class with in vivo inhibition of tumour growth. British Journal of Cancer. 43(4). 505–516. 1 indexed citations
16.
Forbes, James T., et al.. (1980). Human granulocyte-specific nuclear antigen(s). II. Detection of antigens in human proliferative syndromes.. The Journal of Immunology. 124(1). 243–249. 5 indexed citations
17.
Forbes, James T., Filippo Greco, & R. K. Oldham. (1978). Immunologic aspects of small cell carcinoma.. PubMed. 5(3). 263–71. 7 indexed citations
18.
Forbes, James T., et al.. (1977). Soluble tumor antigen‐induced lymphocyte proliferation: Effects of serum from normal and tumor‐bearing mice. International Journal of Cancer. 20(3). 400–407. 3 indexed citations
19.
Kon, Neal D., James T. Forbes, & Paul Klein. (1976). Ability of delayed‐type hypersensitivity reactions to distinguish tumor‐associated antigens and histocompatibility antigens in soluble extracts from murine fibrosarcomas. International Journal of Cancer. 17(5). 613–620. 11 indexed citations
20.
Gainor, Barry J., James T. Forbes, William F. Enneking, & Richard T. Smith. (1976). Specific antigen stimulated lymphocyte proliferation in osteosarcoma. Cancer. 37(2). 743–750. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026